drugset / Trial / NCT01744574

Sex Differences, Hormones & Smoking Cessation

NCT01744574

RandomizedParallel-groupDouble-blindPrevention

Summary

Data suggest that progesterone may improve smoking cessation outcomes perhaps by reducing impulsive behavior. However, the clinical literature on this topic is lacking. Therefore, in Project I we are proposing a double-blind randomized controlled trial to assess the role of exogenous progesterone on impulsivity and smoking cessation in a sample of males and females who are motivated to quit smoking.

Timeline

Start
2012-12
Primary completion
2017-07-27
Completion
2017-07-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Progesterone Other / unclassified 200 mg Oral

Indications